                         SEQUENCE LISTING

<110>  Merino, Edward
       Mulloy, James
       Li, Guorui
       Bell-Horwath, Tiffany
 
<120>  ROS-Activated Compounds as Selective Anti-Cancer Therapeutics

<130>  10738-247

<150>  US 61/605,515
<151>  2012-03-01

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Lab synthesized


<220>
<221>  misc_feature
<223>  Forward primer

<400>  1
ggcctcttcg ctattacgc                                                    19


<210>  2
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Lab synthesized


<220>
<221>  misc_feature
<223>  Reverse primer

<400>  2
atacgcaaac cgcctctc                                                     18


<210>  3
<211>  12
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Lab synthesized

<400>  3
gcgcaattgc gc                                                           12


<210>  4
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Lab synthesized


<220>
<221>  misc_feature
<223>  Erccl forward primer

<400>  4
cgtgctgtac ctctcgc                                                      17


<210>  5
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Lab synthesized


<220>
<221>  misc_feature
<223>  Erccl reverse primer

<400>  5
ctgaggaacg gttcctg                                                      17


